deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01365156

Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix

A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy

Sponsor: M.D. Anderson Cancer Center

Conditions Adenocarcinoma Adenosquamous Carcinoma Cervical Cancer Cervical Squamous Cell Carcinoma Locally Advanced Malignant Neoplasm
Interventions Chemoradiation Extraperitoneal laparoscopic lymphadenectomy (EPLND)
Updated 13 times since 2017 Last updated: Jan 13, 2021 Started: Aug 31, 2011 Primary completion: Jan 24, 2020 Completion: Jan 24, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Adenocarcinoma and Adenosquamous Carcinoma and is currently completed. M.D. Anderson Cancer Center leads this study, which shows 13 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Apr 2017 · 3 months · monthly snapshot~Apr 2017 – ~Jun 2018 · 14 months · monthly snapshot~Jun 2018 – ~May 2019 · 11 months · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Feb 2020 · 8 months · monthly snapshot~Feb 2020 – ~Aug 2020 · 6 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Dec 2022 · 21 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

  5. Mar 2021 — Dec 2022 [monthly]

    Completed PHASE3

▶ Show 8 earlier versions

  1. Jan 2021 — Mar 2021 [monthly]

    Completed PHASE3

  2. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  3. Feb 2020 — Aug 2020 [monthly]

    Active Not Recruiting PHASE3

  4. Jun 2019 — Feb 2020 [monthly]

    Active Not Recruiting PHASE3

  5. May 2019 — Jun 2019 [monthly]

    Active Not Recruiting PHASE3

  6. Jun 2018 — May 2019 [monthly]

    Active Not Recruiting PHASE3

  7. Apr 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

  8. Jan 2017 — Apr 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations